ArticleJournal of thoracic disease2021

Evaluation of pembrolizumab for the treatment of advanced non-small cell lung cancer: a retrospective, single-centre, single-arm study.

Tianxing Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.